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ABSTRACT  Using monoclonal antibodies we have characterized a brain protein that copurifies 
with microtubules. We identify it as a microtubule-associated protein (MAP) by the following 
criteria: (a) it copolymerizes with tubulin through repeated cycles of microtubule assembly in 
vitro; (b) it is not associated with any brain subcellular fraction other than microtubules; (c) in 
double-label immunofluorescence experiments antibodies against this protein stain the same 
fibrous elements in cultured cells as are stained  by antitubulin; and (d) this fibrous staining 
pattern is dispersed  when cytoplasmic microtubules are disrupted by colchicine. Because it is 
distinct from  previously described MAPs we designate  this novel species MAP3. The MAP3 
protein consists of a closely spaced  pair of polypeptides on SDS gels, Mr 180,000, which are 
present in both glial  (glioma  C6) and neuronal (neuroblastoma B104) cell lines.  In brain  the 
MAP3 antigen is present in both neurons and glia. In nerve cells  its distribution  is strikingly 
restricted: anti-MAP3 staining is detectable only in neurofilament-rich axons. It is not, however, 
a component of isolated  brain  intermediate filaments. 
In addition  to the major subunit protein, tubulin,  microtu- 
bules repolymerized in vitro contain a set of minor polypep- 
tides known as microtubule-associated proteins (MAPs).~  It is 
becoming clearer that  microtubules  prepared  from various 
tissues (I,  7,  11,  14)  and  various cell types (8,  15,  18,  20) 
differ in the MAPs they contain. Several MAPs characteristic 
of  brain have been identified, including high molecular weight 
forms usually referred to as MAP1 and MAP2 (3,  13, 25, 29), 
and a  set of related  species of ~60,000  mol wt collectively 
known as tau (30). 
In addition to these, in vitro assembled brain microtubules 
contain many other minor nontubulin components. A recent 
study based on detergent extraction of cultured sympathetic 
neurons suggested the presence of >20 MAPs in these cells 
(7).  In  a  monoclonal antibody  library  constructed  against 
brain MAPs we have found several antibodies that react with 
previously  uncharacterized  microtubule  proteins.  One  of 
these consists of an  180,000 Mr polypeptide doublet, which 
satisfies several criteria for identification as a MAP and which 
we therefore refer to as MAP3. Unlike MAPs 1 and 2, which 
immunohistochemical staining with antibodies  shows to be 
predominantly neuronally localized in brain (5, 9, 10,  16, 21, 
~  Abbreviations  used  in  this paper:  IF,  intermediate  filament;  Ig, 
immunoglobulin;  MAP, microtubule-associated protein. 
22, 31), MAP3 is present in both glial cells and neurons. Its 
most  individual  characteristic  is  a  preferential  association, 
within neurons, with  neurofilament-rich axons and a  corre- 
sponding absence from dendrites. A preliminary report of this 
work has been published (21). 
MATERIALS  AND  METHODS 
Preparation  of Subcellular  Fractions:  Microtubules  were pre- 
pared from the brains of albino rats (body weight 160-180g) by the method of 
Karr et al.  (19). After three  cycles of repolymerization  they  were stored  at 
-70"C until required and then depolymerized and centrifuged at 100,000 g for 
30  min immediately  before use. In some experiments  higher cycle number 
microtubules  were  used  but  this  made  no  difference  in  the  results  of the 
experiments reported here. We made brain intermediate filaments as previously 
described using l mM EGTA in all solutions (details in reference 23). Prelim- 
inary experiments showed that l mM EGTA was as effective as l0 mM EGTA 
in inhibiting Ca2+-induced proteolysis of both microtubule  and intermediate 
filament proteins. Synaptosomes, synaptic membranes, myelin, mitochondria, 
and postsynaptic  densities were prepared  as previously described (23). Brain 
actomyosin was prepared as described by Beach et al. (2). 
Cell  Culture:  Swiss 3T3,  HeLa,  glioma  C6,  neuroblastomas  Bl04, 
NB2A, Nl8, and NIE115  were all  cultured  in Dulbccco's  modified  Eagle's 
medium supplemented  with  10%  fetal calf serum.  After subculture  the cells 
were seeded onto sterile coverslips at  l0  -5 cells/ml  and grown on for 24 h. 
Primary astrocytes  were prepared from cerebella of newborn rats. The tissue 
was chopped, rinsed in phosphate-buffered  saline (PBS;  0.15 M NaCI,  0.05 M 
phosphate buffer, pH 7.4) then dissociated in PBS containing 0.1% trypsin 
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ing 10% fetal ealf serum, and filtered through a fine nylon mesh. The cells were 
washed twice with medium by centrifugation at 1,200 rpm, and the final pellet 
was resuspended in Dulbecco's  medium containing  5% fetal calf serum. The 
cells were plated at a density of 4 x  10J/ml in 35-ram petri dishes containing 
sterile glass coverslips and maintained  at 37"C in 5% CO2 for 5 d before use. 
The coverslips were rinsed in PBS and fixed with either acetone or methanol 
(HeLa ceils only) at -20°C for 5 min then immediately rehydrated in PBS. 
Immunofluorescent  Labeling of Cultured Cells:  Before  im- 
munofluorescent  staining the fixed cells were treated with PBS containing  5% 
fetal calf serum for  10  min to block  nonspecifie  binding.  They  were then 
incubated with monoclonal  anti-MAP3 (1:100 dilution of ascites fluid in PBS) 
for 4 h or, more often, overnight (16 h), then washed with PBS and incubated 
further with rhodamine-labeled  goat anti-mouse  immunoglobulin  (lg; Cappel 
Laboratories,  Cochranville, PA) at  1:50 dilution.  Double immunofluorescent 
labeling was carried out by incubation of  the coverslips first with PBS containing 
1% monoclonal anti-MAP3 and 2% polyclonal (rabbit) antitubulin.  The second 
incubation  was  with  one  of several  combinations  of fluorescently  labeled 
antibodies: rhodamine-labeled goat anti-mouse lg (Nordic, Biogenzia Lemania, 
Lausanne), Texas red-labeled  sheep anti-mouse Ig (Amersham International, 
Amersham, England) or rhodamine-labeled  sheep anti-mouse Ig (Cappel Lab- 
oratories) together with fluorescein labeled goat anti-rabbit  Ig (Nordic, Biogen- 
zia Lemania) or fluorescein labeled swine anti-rabbit lg (Cappel Laboratories 
Inc.). These labeled antibodies were used in pairs, each at 2% concentration  in 
PBS containing  5% fetal calf serum to suppress nonspecifie attachment of the 
label to the sections. Each pair was checked by our incubating it with a section 
that had been exposed to only either anti-MAP3 or antitubulin  and confirming 
that there was no cross-reaction of the anti-rabbit  label with the monoclonal 
antibody or of the anti-mouse label with the rabbit antisera. The use of several 
combinations  reflects changes in the availability and quality of reagents during 
the course of this study. 
Antibodies  and  Related  Procedures:  BALB/c  mice  were im- 
munized with the MAP fraction from third cycle microtubules, and clonal lines 
of antibody-secreting lymphocyte-myeloma hybrid ceils were generated by use 
of standard  techniques  (see reference  16). Positive clones were identified by 
screening against dot-blots of  MAP proteins on nitrocellulose. The MAP species 
with which the antibody of each positive clone reacted was then established by 
immunostainiog nitrocellulose eleetroblots of SDS gels (23) in which microtu- 
bule proteins had been separated. The original anti-MAP3 secreting clone was 
subeloned and five subclones were tested, all of which had identical immuno- 
chemical properties and gave identical tissue and cell staining patterns.  Anti- 
bodies from a single high-producing clone were used for the remainder of this 
study,  lmraunodot assay  with  chain-specific  typing  antisera  identified  the 
antibody as IgG~. Immunochemical  and immunocytochemical  procedures were 
exactly as previously described (16, 24). 
Proteolysis  Experiments:  Supernatant  fractions from rat brains (mi- 
nus the brain stem) were prepared by homogenization  of the tissue in ice-cold 
buffer (100 mM 2-morpholinoethanesulfonic  acid, pH 6.4, 0.5 mM MgCI2, 1 
mM ethylene glyeol-bis(2-aminoethylether)N,N'-tetraacetic  acid) at a ratio of 
1 ml of buffer per gram of tissue and then eentrifogation  in a type 35 rotor 
(Beckman, Geneva) at 30,000 rpm for 45 min. For experiments with calcium 
the supernatant was made 5 mM with respect to CaCI2  before the microtubule 
proteins were added. Aliquots containing 400 gg of mierotubule  protein in 50 
#1 were added to 50 #1 of brain supernatant and incubated at 37"C for various 
times. The reaction was stopped by our making the sample 2% in SDS and 2- 
mereaptoethanoi  and immediately heating it to 90"C for 5 min. 
RESULTS 
Characterization ofthe Monoclonal Antibody 
and its Antigen 
The distinguishing features of the antibody are the charac- 
teristic staining pattern it gives on brain sections (see below) 
and its selective reaction with a subclass of brain MAP pro- 
teins (Fig. 1). On nitrocellulose blots of SDS gels, the strongest 
reaction was with a pair of polypeptides that migrate with an 
Mr of 180,000. The antibody also reacted more weakly with 
doublet bands at ~ 170,000 and 150,000. There was no reac- 
tion with tubulin, MAP 1 or MAP2, or with MAPs of the tau 
group. In addition to its reaction with these polypeptides on 
SDS gel blots, the antibody also gave a positive reaction with 
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FIGURE  I  Reaction  of 
anti-MAP3 monoclonal an- 
tibody with brain microtu- 
bular  proteins.  Rat  brain 
microtubule  protein  was 
run  in  a  broad slot on  an 
SDS  polyacrylamide  gel. 
The  separated  proteins 
were blotted onto a nitro- 
cellulose sheet which was 
cut  into  several  vertical 
strips, each with an identi- 
cal  content  of  peptide 
bands. Strip  I  was stained 
with  amido black for  pro- 
tein  whereas  strip  2  was 
stained  with  anti-MAP3. 
The  positions  of  MAPI, 
MAP2,  and  tubulin  (Tub) 
are  indicated  with  some 
molecular weights (x 10-3). 
native MAPs  (i.e.,  not SDS  denatured) on cellulose nitrate 
dots. 
All  the  bands  stained  by  the  antibody  showed  selective 
copolymerization with tubulin (Fig.  2 and Table I) and were 
absent from the warm supernatant to the assembled micro- 
tubules (Fig.  1, sample 5). Thus, from the brain homogcnate 
through  the  first  two  cycles  of  microtubulc  assembly  the 
reactive bands were progressively enriched in the microtubule 
fraction  (compare  samples  1,  4,  and  8,  Fig.  2)  and  they 
remained  in  the  microtubules  at  the  same  relative  level 
through subsequent cycles of assembly and disassembly (com- 
pare samples 8  and 11,  Fig.  2). During this procedure there 
was a  noticeable increase  in the amount of material in the 
lower molecular weight bands relative to the 180,000 doublet 
(compare  samples  4,  6,  9,  and  12,  Fig.  2b).  This probably 
reflects  degradation by residual protcases in the samples (see 
below). 
Microtubular Localization 
To confirm that the antigenic protein was associated with 
microtubules in vivo, we used the antibody to stain cultured 
cells. In one series of experiments we double labeled astrocytes 
in primary brain cell  cultures with monoclonal anti-MAP3 
Characterization  of a Novel Microtubule-associated  Protein  497 FIGURE  2  The partitioning of MAP3  during three cycles of micro- 
tubule  assembly.  Samples  were  taken  at  each  step  during the 
preparation of microtubules and run on SDS gels; the same amount 
of protein (10 #g) was loaded in each channel, a shows the Coo- 
massie Blue-stained gel on which the positions of MAPI,  MAP2, 
and tubulin are marked (I, 2 and T). b shows an anti-MAP3 stained 
nitrocellulose blot of an identical gel. A key to the different samples 
appears in Table I. 
and rabbit antiserum against tubulin.  In all cells the distri- 
bution  of MAP3  (Fig.  3,  b  and  d)  coincided with that  of 
antitubulin stained fibers (Fig.  3, b and c). In a second series 
of experiments we used anti-MAP3 to stain glioma C6 cells 
in cultures, some of which had been exposed to colchicine 
before fixation. The untreated controls showed a microtubular 
staining pattern (Fig. 4a) similar to that found in the primary 
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TABLE  I 
Partitioning of MAP3 during Microtubule Assembly 
Sample  MAP3 
No.*  Sample  status 
1  Brain homogenate, 2°C  u 
2  Supernatant from sample 1  w 
3  Pellet from sample I  u 
4  First cycle microtubules (pellet after assembly  e 
of sample 2) 
5  Supernatant to sample 4  u 
6  Disassembled microtubules  e 
7  Cold-insoluble (2°C)  pellet from sample 4  d 
8  Second cycle microtubules  e 
9  Depolymerized microtubules from sample 8  e 
10  Cold-insoluble pellet from sample 9  d 
11  Third cycle microtubules  e 
12  Disassembled  microtubules fromsample 11  e 
13  Cold-insoluble pellet from sample 11  d 
e, enriched; u, undetectable; d, depleted; w, weak. 
* Sample numbers correspond to slot numbers in Fig. 2. 
astrocytes. The colchicine treated cells were still  stained by 
the antibody but the fibrillar staining pattern was no longer 
visible (Fig. 4 b). 
Origin of the Lower Mr Bands Stained by 
the Antibodies 
In addition to the major 180,000  pair stained by the anti- 
body, all brain microtubule preparations contained lower Mr 
anti-MAP3  reactive bands,  the  amount of which  varied in 
different microtubule preparations. This could be explained 
by MAP3's being susceptible to degradation by endogenous 
brain proteases active during microtubule isolation. To test 
this, we exposed brain microtubules to separately prepared 
brain high speed supernatant at 370C and looked for evidence 
of breakdown of the  180,000  doublet to the lower molecular 
weight forms. Degradation of MAP3 occurred to the greatest 
extent in the presence of added calcium, but also when excess 
EGTA was added to sequester calcium (Fig.  5 a). 
In all of the lower Mr products the doublet appearance of 
the immunoreactive material was preserved, which suggests 
that the removal of identical segments from each of the two 
native 180,000 Mr polypeptides at each step of  the degradative 
process occurred. The presence of these anti-MAP3 reactive 
fragments in  freshly prepared brain  microtubules  was  not 
eliminated  by  EGTA  or  by other  inhibitors  of the  major 
categories of proteases, including phenylmethylsulfonylfluo- 
ride, p-hydroxymercuribenzoate, o-phenanthroline, and leu- 
peptin. 
Cellular Distribution of MAP3 
We examined a variety of ceil lines for evidence of MAP3 
content. In one series of experiments brain microtubules and 
brain  homogenate  (serving  as  positive  controls)  were  run 
alongside homogenates of the various test ceils in a single slab 
SDS-gel. The entire gel was blotted onto cellulose nitrate and 
stained with the antibody. The results of one such experiment 
are shown in Fig.  6.  In this case two identical gels were run 
and blotted, one of which was stained with Coomassie Blue 
to reveal the pattern of major proteins in the different cell 
types (Fig.  6 a) and the other blotted onto nitrocellulose and 
stained with anti-MAP3  (Fig.  6 b).  With  respect to protein FIGURE 3  Immunofluorescent double labeling of cells in primary brain cell cultures by polyclonal antiserum against tubulin (a 
and c) and monoclonal antibodies against MAP3 (b and cO. 
content the various neuroblastomas (slots 7 to 16) are quite 
similar to one another as well as to the glioma cells (slots 5 
and 6) and to brain homogenate (slots 3 and 4). However, in 
MAP3  content  there are marked differences between these 
various cell lines (Fig.  6 b). When brain homogenate (slots 3 
and 4) are used as a standard, it is clear that glioma C6 cells 
are relatively rich in MAP3 (slots 5 and 6). This is also evident 
by immunofluorescent staining (Fig. 4 a). Among the neuro- 
blastoma cell lines there is a marked contrast between B104, 
which does produce MAP3, and all of the other neuroblasto- 
mas tested (NB2A, N-18, and NIE-115), in which the antigen 
is undetectable.  In BI04 cells the level of MAP3  immuno- 
reaction relative to total cellular protein is markedly increased 
when the cells are induced to differentiate by application of 
cyclic AMP (compare slots 7and 8 and 9 and 10, Fig. 6b). 
The experiment shown in Fig. 6 is one of several in which 
we compared microtubules and brain homogenate by use of 
anti-MAP3. A consistent feature of these experiments is the 
HUBER ET AL.  Characterization  of a Novel Microtubule-associated  Protein  499 FIGURE  4  Glioma C6 cells stained with monoclonal anti-MAP3. The cells in a were in an untreated control culture whereas the 
cells in b were in a culture that was treated with colchicine (1  x  10  -6 M) for 2 h before fixation. 
evident specificity of the monoclonal antibodies for MAP3. 
Thus, in brain homogenate no proteins other than the 180,000 
doublet react with anti-MAP3  (Fig.  6 b,  slots 3  and 4).  We 
also observed by comparing anti-MAP3 reactive material in 
cell lines with that in repolymerized brain microtubules, the 
relative lack of lower .4,I, degradation products. For example, 
the very strong 180,000  MAP3 doublet in C6 cells is accom- 
panied by a much weaker immunoreactive doublet at 170,000 
and  no  further  breakdown  products  (Fig.  6b,  slot  5).  In 
comparison,  brain  microtubules  in  the  same  gel  give  less 
staining of the 180,000  doublet but much more intense lower 
Mr bands (slot 1). 
In addition to neuroblastoma and glioma we also examined 
two non-neural cell lines, Swiss 3T3 and Hela cells.  Neither 
of these contained immunoreactive MAP3 when cell homog- 
enates were  tested  by solid-phase immunoassay with  anti- 
MAP3.  Each of these cell lines was also checked for immu- 
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nofluorescent staining by anti-MAP3,  but there was no de- 
tectable reaction. We also tested a  series of other brain sub- 
cellular fractions by staining SDS-gel blots with anti-MAP3. 
In none of these, actomyosin, myelin, mitochondria, synaptic 
membranes, and postsynaptic densities, was MAP3 detecta- 
ble. 
Distribution of MAP3 in Brain 
In brain sections MAP3  shows a  distinctive distribution, 
being restricted to astroglial cells and neurofflament-rich ax- 
ons. This is well demonstrated in two tissues, the cerebellum 
and the hippocampus. 
In the cerebellar cortex (Fig.  7) both types of staining are 
already  apparent  at  low  magnification  (Fig.  7,  a  and  b). 
Myelinated axons in the white matter are strongly labeled and 
the radially oriented fibers of the Bergmann glial cells in the FIGURE  5  Anti-MAP3-stained SDS gel blots of total proteins from microtubules that had been incubated with brain supernatant 
for the times indicated (in hours) beneath each channel, a shows the different effects of incubation with or without Ca  2+ for 7 h. 
b shows the time course for degradation in the presence of Ca  2+. 180, 180,000 tool wt. 
outer molecualr layer are also prominently stained.  Closer 
examination of the  white  matter in  transverse (Fig.  7c)  or 
longitudinal  (Fig.  7d)  section  confirms that  the  staining is 
present in the axoplasmic cores of all the white matter axons. 
The myelin sheaths around the axons (arrowheads) are un- 
stained. 
At higher magnification the stained Bergmann glial fibers 
are clearly resolved (Fig. 7 e), and the lack of staining of  either 
axons or dendrites in the neuropil above the Purkinje cells is 
also apparent.  Outside  of the white matter only one set of 
neuronal processes shows any MAP3 staining. These are the 
terminal arborizations of basket cell axons which, as shown 
in Fig. 7f, are labeled by anti-MAP3 as they make their typical 
basket-like enclosure around the cell bodies and initial axons 
segments of Purkinje cells. 
In the hippocampus, the anti-MAP3 staining pattern is also 
distinctive. Throughout,  there is staining of scattered small 
cell (Fig.  8 a), which at higher magnification are revealed as 
astroglia (Fig. 8, b and c). Neuronal MAP3 immunoreactivity 
in the hippocampal formation is limited to a single tract, the 
mossy  fibers.  This  tract  consists  of the  axons  of granule 
neurons  in  the  dentate  gyrus which  terminate  in  synapses 
onto proximal regions of the apical dendrites of pyramidal 
neurons in the CA3 area of the hippocampal gyrus. The anti- 
MAP3  staining  in  the  hippocampus  followed  exactly  this 
pattern, showing strong staining of  axons arising in the dentate 
gyrus (Fig. 8 b) and running as a tract just superior to the CA3 
pyramidal  cell  bodies.  The  staining  became  progressively 
weaker along the course of  the CA3 region (Fig. 8 a), reflecting 
the progressive thinning out of the tract as more axons ter- 
HUaER IT AL.  Characterization  of a Novel Microtubule-associated Protein  501 FIGURE 6  Tests  for the presence of MAP3 in neural cell lines, a shows a gel stained with Coomassie Blue for proteins; b shows 
an anti-MAP3-stained nitrocellulose blot from a gel run in parallel. Channels I, 3, 5, 7, 8,  11, and 13-16 were loaded with 40/zg 
of protein, the others  with 20/~g. The different channels  contain proteins of (1  and 2)  brain microtubules, (3 and 4)  brain 
homogenate, (5 and 6) glioma C6 (7 and 9) neuroblastoma B104 grown without cyclic AMP, (8 and I0) B104 grown with cyclic 
AMP (11 and 12) neuroblastoma N2a (13 and 14) neuroblastoma N 118, and (15 and  16) neuroblastoma NIE115. 
minate. Within the tract itself  both the stained fibers and glial 
cell bodies are visible (Fig. 8 d). 
The pattern of nerve cell staining in brain sections by anti- 
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MAP3  parallels  the  distribution  of intermediate  filaments 
(IFs). Thus  myelinated axons,  cerebellar basket cell axons, 
and hippocampal mossy fiber axons are all rich in neurofila- FIGURE  7  Sections  of cerebellar cortex stained  with anti-MAP3. (a) Central area showing white mater  (win).  The granule cell 
layer (g/) and the molecular layer (ml) are identified. (b) A single folium. (c) The area labeled c in a. (d) The area labeled d in b. (e) 
The Purkinje cell layer showing stained Bergmann glial fibers (Bgf) and stained astrocytes among the unstained granule cell bodies 
(arrowheads).  (f) Close-up of Purkinje cell bodies (P) to show the stained  basket  cell axon terminal arborizations (bx) around 
Purkinje cell initial axon segments. Bars, (a and b) 100/~m; (c and d) 25/~m;  (e) 50/Lm; and (f) 20 p.m. 
503 FIGURE  8  Hippocampus stained with anti-MAP3.  (a) An entire section with the mossy fiber tract (mr) and the layer of granule 
cells (gc), from which these axons arise labeled. The areas covered by b and c are also indicated. (b) The mossy fiber tract at its 
area of origin in the dentate gyrus. (c) Part of the CA1  portion of the hippocampal gyrus around the pyramidal cell layer (the layer 
of pyramidal cell bodies is labeled 'pyc'). Some of the stained astrocytes are indicated with arrowheads. (d) Stained fibers (mr) in 
the mossy fiber tract. Stained glial cells are indicated (arrowheads). Bars, (a) 0.5 ram; (b) 100/~m; (c) 50/~m; and (d) 25/~m. 
504 ments (Fig. 9 and reference 32), and the astroglial cells stained 
by anti-MAP3  are  rich  in  glial  filaments (6,  23,  27).  We 
therefore considered the possibility that,  in  addition to  its 
relationship with microtubules, MAP3 might also be associ- 
ated with brain intermediate filaments. To test this, we made 
brain IF preparations that contained both neuronal and glial 
filaments (12,  23) and examined them to see whether they 
contained MAP3. Fig.  l0 shows two SDS-gel blots of brain 
IFs (slots  1 and 2) and two blots of brain microtubules to 
serve as controls (slots 3 and 4). The microtubule blot shows 
the usual pattern of MAP3-reactive bands. By contrast the IF 
blot,  although  loaded  with  the  same  amount  of protein, 
contains no anti-MAP3 reactive material (slot 1). The brain 
IF preparations used in this study were made in the presence 
of  l  mM  EGTA  and  protease  inhibitors  (for  details  see 
reference 23) so the absence of  MAP3 from these preparations 
cannot be attributed to proteolytic degradation. 
DISCUSSION 
The monoclonal antibody described in this study reacts with 
a protein antigen, which satisfies several criteria for its iden- 
tification as a MAP. First, MAP3 is present in brain micro- 
tubules but absent from all other subcellular fractions. Second, 
it  repeatedly copolymerizes with  tubulin  through  multiple 
cycles of microtubule assembly and disassembly. Third, in 
cultured cells anti-MAP3  decorates the same set of fibrous 
elements  that  are  stained  by antitubulin.  Fourth,  in  cells 
whose microtubules have been disrupted with colchicine anti- 
MAP3 staining loses its fibrillar pattern. 
The MAP with which our antibodies react is novel in that 
it does not correspond to the previously characterized brain 
microtubular proteins MAP1, MAP2, or tau. It is also distinct 
from the 210,000 mol wt Hela cell MAP (8),  since MAP3 
immunoreactivity is absent from Hela cells by both immu- 
nochemical  and  immunofluorescence tests.  MAP3  is  also 
distinct from another recently described MAP of -200,000 
Mr (l 8) because the latter is limited to microtubules of the 
mitotic  spindle  and  is  apparently  absent  from  interphase 
microtubules. On the contrary, anti-MAP3 stains interphase 
microtubules in cultured cells. 
Most of the MAP3 protein in brain consists of a  pair of 
polypeptides close in size. Like other high molecular weight 
MAPs (16, 26, 28), both components of the MA3 doublet are 
highly susceptible to proteases present in brain supernatant, 
particularly  in  the  presence  of calcium.  EGTA  markedly 
slowed the degradation of MAP3  180,000 by brain superna- 
tant but it did not totally eliminate the breakdown products 
from brain microtubules, and neither did any of a variety of 
protease inhibitors. Thus, it seems possible that these break- 
down products may already be present in brain,  produced 
through the in vivo activity of the same calcium-stimulated 
protease that can be demonstrated in brain  supernatant in 
vitro. Such a scheme has already been suggested for MAPs 1 
and 2 on the basis of similar data (26). 
The MAP3 antigen occurs in both neurons and glia, which 
FIGURE 9  Comparison of anti-MAP3 and anti-neurofilament  (anti- 
NF) staining patterns. (a and b) Purkinje cell layer of the cerebellar 
cortex stained  with anti-MAP3 (a) or anti-NF  (b). Stained  basket 
axon terminals forming typical  pinceau  (pin)  formations around 
Purkinje  cell  initial  axons  segments  are  indicated.  The  stained 
preterminal axons of basket cells are identified by arrowheads.  (c 
and d) Hippocampus slices stained with anti-MAP3 (c) or anti-NF 
(d). The mossy fiber tracts arising from the dentate gyri  (dg} are 
marked  with  arrowheads.  The background  coloration with  anti- 
MAP3 is the result of astrocyte staining. 
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that each  of the MAPs  they recognize is  associated with a 
different population of microtubules in vivo. For example, in 
the cerebellar cortex, strong MAP3 immunoreactivity is pres- 
ent in all the myelinated axons of the white matter. Many of 
these MAP3-positive axons belong to Purkinje cells, in which 
we have recently demonstrated that MAPs 1 and 2 are differ- 
ently distributed (16).  It thus appears that there are at least 
three different types of microtubules in the principal neurons 
of the cerebellar cortex, each characterized by different MAP 
species. 
MAP3 is codistributed with neurofilaments in nerve cells; 
it  is  present  only  in  neurofdament rich  axons,  and  within 
those axons immunoreactive MAP3 first appears just beyond 
the initial axon segment in just the same way as neurofilament 
antigen (Fig.  9).  This suggests that  neuronal MAP3  is  inti- 
mately connected with neurofilaments, despite its being an 
integral component of isolated microtubules but not of iso- 
lated  neurofilaments.  In  the  developing  brain,  however, 
MAP3 is transitorily expressed in growing axons from which 
it is absent in the adult. At least some categories of such axons 
do not contain neurofilaments either during development or 
in the adult brain. For example the axons ofcerebellar granule 
cells are rich in MAP3 between the first and third postnatal 
weeks but thereafter MAP3 is not detectable in these ceils (4). 
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and the photographic work was performed by M. Ackermann and E. 
Peter. 
Received for publication  12 March  1984, and in  revised form  12 
October 1984_ 
FIGURE  10  Comparison  of  the  MAP3  contents  of  brain  IFs  and 
microtubules (MTs).  Strips  1 and 2 were cut from a single nitrocel- 
lulose  blot of an SDS  gel  in  which  brain  IFs were  run.  Similarly, 
strips 3 and 4  were from  a  single blot of a  brain M1  ~ gel. Strips 2 
and 4  were stained for  protein with  amido  black.  Strips  1 and  3 
were stained with anti-MAP3 under identical conditions. Gel Ioad- 
ings weEe 10/~g/mm in 0.8-ram thick slots. 
raises  the  possibility  that  one  component  of the  180,000 
doublet might be present in neurons and the other in gila. 
However, this is unlikely to be the case because both com- 
ponents are present in glioma (C6) as well as neuroblastoma 
(B 104) cells. 
In neurons MAP3 has a highly restricted cytoplasmic dis- 
tribution. Unlike MAP 1, which is more concentrated in den- 
drites than axons (16,  17,  31), and MAP2, which appears to 
be exclusively located in the dendrites of brain neurons (4, 5, 
9,  10,  19,  31), MAP3 appears to be completely absent from 
dendrites and is instead exclusively located in neurofilament 
rich axons. In this respect our monoclonal antibodies against 
MAPI,  MAP2,  and MAP3  act as controls for one another, 
each being  IgGt  immunoglobulins (16)  and each giving  its 
own distinctive staining pattern. The very different intraneu- 
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